Introduction
SARS-CoV-2 has been associated with an increased incidence of
thromboembolic events, including pulmonary embolism, in up to 20% of
adult patients with COVID-191. While the data in
pediatric patients are less robust, older teenagers with MIS-C have been
reported to have pulmonary embolism2. MIS-C has been
defined in recent literature by the six following criteria: serious
illness leading to hospitalization, age less than 21 years, fever
>38.0°C or report of subjective fever lasting at least 24
hours, laboratory evidence of inflammation, multisystem organ
involvement involving at least two systems, and laboratory confirmed
SARS-CoV-2 infection (positive SARS-CoV-2 PCR or positive antibody test
during hospitalization) or an epidemiologic link to a person with
COVID-192. We describe the case of a 15 year old
female with a positive SARS-CoV-2 IgM antibody test during admission
with bilateral pulmonary emboli requiring catheter directed thrombolysis
for resolution.